OCT 29, 2021 8:00 AM PDT

A novel analogue of psilocin to treat mental health disorders

WRITTEN BY: J. Bryce Ortiz

Psilocybin and its metabolite psilocin are naturally occurring compounds that are commonly found in some genus of mushrooms. Psilocybin is more commonly referred to as the active ingredient in magic mushrooms. When psilocybin is ingested, the body metabolizes it into psilocin, which produces many of the mind-altering effects. These effects include feelings of euphoria, visual and mental hallucinations, distorted perception of time, and difficulty in discerning fantasy from reality. 

The mechanisms by which psilocin exerts these psychedelic effects occurs through activating receptors in the brain that respond to the neurotransmitter serotonin. Because of this, it has been postulated that psilocybin could be an effective treatment for mood disorders and addiction which are, in part, caused by disruption of the brain’s serotonin systems. In the past couple of decades, psilocybin has shown promise in treating mental disorders such as anxiety and depression. In one recent study it was shown that psilocybin was just as effective in treating depression and anxiety when compared to the most commonly prescribed antidepressant medication. As such, psilocybin has immense promise in the treatment of mental health disorders. With that in mind, now psilocybin centers are slowly opening up around the world to help people treat a variety of the mentioned symptoms.

Yesterday, Mydecine, a biotechnology company, announced that it has successfully synthesized a novel psilocin analogue. The company stated that the new analogue has improved pharmaceutical properties and is a good candidate that can one day be used for therapy to combat mental health disorders. 

Interestingly, this novel drug was discovered using Mydecine’s artificial intelligence (AI) drug discovery program. The drug discovery world frequently uses AI to quickly screen drug libraries and identify novel compounds. Rob Roscow, Chief Scientific Officer at Mydecine, said, “Our ability to rapidly uncover safer and more efficacious novel compounds, such as this psilocin analogue, is a true testament to the value and success of our AI-driven drug discovery program.” With this novel compound and others, Mydecine hopes to transform the treatment and improve the lives of individuals suffering from mental health disorders. 

 

 

Sources: Cleveland ClinicLabrootsNew England Journal of MedicineMydecineTwitternature

About the Author
PhD in Neuroscience
Science and medical writer | Researcher | Interested in the intersection between translational science, drug development, and policy
You May Also Like
MAR 29, 2022
Cannabis Sciences
Teen Mental Health: A Key Factor in Transitioning from Vaping to Cannabis Use
MAR 29, 2022
Teen Mental Health: A Key Factor in Transitioning from Vaping to Cannabis Use
Georgia State University (GSU) researchers conducted a study to understand the link between teen e-cigarette use and sub ...
MAR 29, 2022
Drug Discovery & Development
Nasal Spray Shows Promise Against All Variants of SARS-CoV-2
MAR 29, 2022
Nasal Spray Shows Promise Against All Variants of SARS-CoV-2
A compound delivered via a nasal spray can prevent and treat various COVID-19 variants in mice. The corresponding study ...
APR 01, 2022
Cannabis Sciences
Cannabigerol's Potential to Trigger Neuroregeneration
APR 01, 2022
Cannabigerol's Potential to Trigger Neuroregeneration
Cannabigerol (CBG) has significant potential to treat neurological disorders according to a recent study published in Ph ...
APR 20, 2022
Drug Discovery & Development
Vitamin E Stimulates Dendritic Cells, Boosts Immunotherapy Effectiveness
APR 20, 2022
Vitamin E Stimulates Dendritic Cells, Boosts Immunotherapy Effectiveness
Dendritic cells play an important role in the immune system. Specifically, they help gather up antigen-presenting cells ...
APR 21, 2022
Health & Medicine
Inhibiting a Key Signaling Pathway in Immune Cells Slows Alzheimer's Progression
APR 21, 2022
Inhibiting a Key Signaling Pathway in Immune Cells Slows Alzheimer's Progression
Weill Cornell Medicine researchers recently discovered that inhibiting a key signaling pathway in brain cells can lessen ...
MAY 13, 2022
Drug Discovery & Development
Opioid Addiction Treatments Minimize Fetal Brain Changes
MAY 13, 2022
Opioid Addiction Treatments Minimize Fetal Brain Changes
The rise in opioid use, addiction, and overdose is a serious public health matter. Almost 850,000 people have died of dr ...
Loading Comments...